104 related articles for article (PubMed ID: 34197784)
1. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effect of low-molecular-weight heparin in prevention and treatment of liver cirrhosis and portal vein thrombosis after splenectomy: a systematic review and meta-analysis].
Zhang W; Zhou DM; Li Y
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):732-737. PubMed ID: 27938557
[No Abstract] [Full Text] [Related]
3. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
[TBL] [Abstract][Full Text] [Related]
4. How to manage splanchnic vein thrombosis in patients with liver disease.
Riva N; Ageno W
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
[TBL] [Abstract][Full Text] [Related]
5. A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis.
Wang L; Xu Z; Zhang L
J Musculoskelet Neuronal Interact; 2024 Jun; 24(2):185-191. PubMed ID: 38826001
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH.
Roberts LN; Hernandez-Gea V; Magnusson M; Stanworth S; Thachil J; Tripodi A; Lisman T
J Thromb Haemost; 2022 Oct; 20(10):2237-2245. PubMed ID: 35948998
[TBL] [Abstract][Full Text] [Related]
7. Treatment of portal vein thrombosis in cirrhosis patients.
Téllez L; Guerrero A; Albillos Martínez A
Rev Esp Enferm Dig; 2023 Dec; 115(12):682-685. PubMed ID: 37522304
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.
Tadokoro T; Tani J; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Fujita K; Nomura T; Morishita A; Kobara H; Himoto T; Ono M; Masaki T
Sci Rep; 2024 May; 14(1):10784. PubMed ID: 38734732
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety Study of Low-Molecular-Weight Heparin and Fondaparinux Sodium After Hip Arthroplasty: A Retrospective Cohort Study.
Haibier A; Yusufu A; Lin H; Kayierhan A; Abudukelimu Y; Abudurexiti T
Orthop Res Rev; 2023; 15():253-261. PubMed ID: 38033454
[TBL] [Abstract][Full Text] [Related]
10. Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis.
Liao Z; Wang Z; Su C; Pei Y; Li W; Liu J
PLoS One; 2023; 18(8):e0290164. PubMed ID: 37582105
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.
Mier-Hicks A; Raj M; Do RK; Yu KH; Lowery MA; Varghese A; O'Reilly EM
Clin Colorectal Cancer; 2018 Jun; 17(2):121-128. PubMed ID: 29477452
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in cirrhosis: a new paradigm?
Leonardi F; Maria N; Villa E
Clin Mol Hepatol; 2017 Mar; 23(1):13-21. PubMed ID: 28288507
[TBL] [Abstract][Full Text] [Related]
13. Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis.
Senzolo M; Rodriguez-Castro KI; Rossetto V; Radu C; Gavasso S; Carraro P; Zerbinati P; Sartori MT; Simioni P
J Thromb Haemost; 2012 Sep; 10(9):1823-9. PubMed ID: 22712870
[TBL] [Abstract][Full Text] [Related]
14. A major research gap: The use of anticoagulants in cirrhosis.
Senzolo M; Garcia-Pagan JC
J Hepatol; 2023 Dec; 79(6):1566-1570. PubMed ID: 37302580
[TBL] [Abstract][Full Text] [Related]
15. How to treat patients with splanchnic vein thrombosis: recent advances.
Valeriani E; Menichelli D; Palumbo IM; Cammisotto V; Pastori D; Pignatelli P
Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 37171365
[TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy of Anticoagulant Medications in Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis-A Systematic Review and Network Meta-analysis.
Ghazaleh S; Chuang J; Sayeh W; Iqbal A; Beran A; Khader Y; Burmeister C; Aziz M; Assaly R; Nawras A
Am J Ther; 2023 Nov-Dec 01; 30(6):e591-e594. PubMed ID: 36927678
[No Abstract] [Full Text] [Related]
17. A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism.
Oktaviana J; Lui B; Ho P; Lim HY
Blood Coagul Fibrinolysis; 2023 Apr; 34(3):191-198. PubMed ID: 36966765
[TBL] [Abstract][Full Text] [Related]
18. Renal vein thrombosis in neonates: a case series of diagnosis, treatment and childhood kidney function follow-up.
Ndoudi Likoho B; Berthaud R; Dossier C; Delbet JD; Boyer O; Baudouin V; Alison M; Biran V; Hurtaud MF; Hogan J; Kwon T; Couderc A
Pediatr Nephrol; 2023 Sep; 38(9):3055-3063. PubMed ID: 36988695
[TBL] [Abstract][Full Text] [Related]
19. Portal vein thrombosis as extraintestinal complications of Crohn's disease: a case report and review of literature.
Alhalabi M; Nasri D; Aji W
J Med Case Rep; 2024 May; 18(1):246. PubMed ID: 38741148
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation for cirrhosis with portal vein thrombosis: Still a road to be explored.
Chen X; Pan J; Zhu Y
J Hepatol; 2024 May; 80(5):e204-e205. PubMed ID: 37832603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
